Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

Corneal Staining Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00483795
• Other study ID #: 5308
• Status: Completed
• Phase: Phase 4
• First received: June 1, 2007
• Last updated: July 23, 2007

Study information

• Verified date: July 2007
• Source: Innovative Medical
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients 18 yrs or older

• Males or females

• Any race or ethnic background

• CL patients using (multipurpose solutions) MPS

• Patients using Acuvue 2 lenses

Exclusion Criteria:

• Corneal refractive surgery within 6 months of this study.

• Contact lens use on day of examination.

• Corneal ectasia.

• Current use of Restasis

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind

Related Conditions & MeSH terms

• Corneal Staining

Intervention

Drug:
• sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95

Locations

Country	Name	City	State
United States	Hazleton Eye Specialists	Hazleton	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Innovative Medical

Country where clinical trial is conducted

United States,